Lisinopril vs Pembrolizumab

## Lisinopril vs Pembrolizumab: Overview

This comparison examines the pharmacological differences between **Lisinopril** and **Pembrolizumab**.

## Mechanism of Action

**Lisinopril**: ACE inhibitor preventing conversion of angiotensin I to angiotensin II.

**Pembrolizumab**: Anti-PD-1 monoclonal antibody restoring anti-tumor immunity.

## Pharmacokinetics

**Half-life**: Lisinopril — 12 hours; Pembrolizumab — 26 days.

## Chemical Properties

**Molecular Formula**: Lisinopril — C21H31N3O5; Pembrolizumab — N/A.

**Molecular Weight**: Lisinopril — 405.4900 g/mol; Pembrolizumab — N/A.

**Type**: Lisinopril — Small molecule; Pembrolizumab — Antibody.